Core cash flow generation appears distorted, as evidenced by an extreme OCF/NI ratio of 2818.84 in 2026Q2, which reflects significant non-operating liquidity management rather than organic operational efficiency.
| Cash from Operations | 2B | 1.45M | 416.55K | 1.99M | 825.53K | 1.03M | 1.06M | 461.23K |
| Operating CF Growth % | 1307222.82% | 247.74% | -79.06% | 140.95% | -20% | -3.04% | 130.75% | - |
| Net Income | 1.1M | 42.45K | -186.99K | 1.67M | 1.33M | 1.37M | 417.87K | 1.33M |
| Depreciation & Amortization | 212.52M | 295K | 244.9K | 205.01K | 207.95K | 207.35K | 175.29K | 149.53K |
| Deferred Taxes | -28.93M | 0 | 0 | 0 | 362.68K | 458.42K | 93.6K | 0 |
| Other Non-Cash Items | 267.53M | 8.89K | 530.62K | -716.83K | -1.02M | -930.41K | -9.28K | -1.17M |
| Working Capital Changes | -696.29K | 883.83K | -365.01K | 658.12K | -110.84K | -84.3K | 386.79K | -14.13K |
| Cash from Investing | -10.77B | -15.58M | 17.71M | -14.42M | -44.22M | -20.83M | 3.48M | -5.81M |
| Purchase of Investments | 0 | 0 | 0 | 0 | -3.5M | -1.11M | -3.22M | 0 |
| Sale/Maturity of Investments | 1.31B | 1.74M | 2.3M | 1.06M | 3.18M | 7.24M | 9.26M | 8.65M |
| Net Investment Activity | 1.31B | 1.74M | 2.3M | 1.06M | -315.92K | 6.12M | 6.04M | 8.65M |
| Acquisitions | 0 | 100K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing | -12.05B | -17.24M | 17.68M | -15.42M | -43.87M | -26.86M | -2.27M | -13.92M |
| Cash from Financing | 8B | 18.05M | -19.43M | 15.78M | 5.77M | 41.57M | 17.12M | 2.48M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -37.66K | -82.17K | -156.22K | -1.37M | 0 | 0 | 0 | 0 |
| Stock Issued | 15.2M | 15.21M | 0 | 0 | 0 | 8.51M | 0 | 0 |
| Net Stock Activity | 15.16M | 15.13M | -156.22K | -1.37M | 0 | 8.51M | 0 | 0 |
| Debt Issuance (Net) | 0 | 1000K | 1000K | 1000K | -1000K | -1000K | 1000K | 0 |
| Other Financing | 7.98B | 918.67K | -24.27M | 9.15M | 16.14M | 37.07M | 2.75M | 2.48M |
| Net Change in Cash | -768.23M | 3.91M | -1.3M | 3.35M | -37.62M | 21.77M | 21.67M | 2.61M |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.49M |
| Cash at Beginning | 13.66B | 10.47M | 11.78M | 8.43M | 46.05M | 24.27M | 2.61M | 0 |
| Cash at End | 13.63B | 14.39M | 10.47M | 11.78M | 8.43M | 46.05M | 24.27M | 2.61M |
| Interest Paid | 2.86M | 3.52M | 3.38M | 2.23M | 944.13K | 1.07M | 1.36M | 0 |
| Income Taxes Paid | 140K | 0 | 261K | 159K | 79K | 10K | 0 | 0 |
| Free Cash Flow | 1.97B | 1.27M | -1.85M | 1.92M | 791.44K | 943.46K | 772.03K | -79.02K |
| FCF Growth % | 97722.94% | 168.68% | -196.08% | 143.07% | -16.11% | 22.21% | 1077.03% | - |
High Operating Expense Ratio
According to the reported cash flow data, MBBC's net income remains modest, with quarterly figures hovering near $487.9K in 2026Q3, suggesting that the bank's ability to generate organic capital is currently constrained by its limited scale and the high overhead costs inherent in its current operating model.
The bank's reliance on internal capital generation is hampered by thin net margins, which limits the capacity to fund significant loan growth without external support. Investors should monitor whether the bank can transition from its current startup-like phase to a more sustainable profitability profile that supports long-term regulatory capital requirements.
As indicated by the 2026Q2 financial statements, MBBC executed a substantial $1.2 billion in securities sales, a figure that dwarfs the bank's typical quarterly activity and suggests a tactical shift in liquidity management rather than a routine adjustment of the investment portfolio's duration or yield profile.
The massive variance in securities sales across recent quarters implies that the bank is utilizing its investment portfolio as a primary liquidity buffer to manage balance sheet volatility. This strategy warrants further investigation, as it may indicate that the bank is forced to liquidate assets to meet funding needs rather than maintaining a stable, income-generating securities book.
Based on the provided cash flow records, the bank's provision for credit losses has exhibited significant volatility, swinging from a $95.0K charge in 2025Q4 to a $40.0K benefit in 2026Q1, which complicates the assessment of the bank's true underlying credit quality and earnings stability.
This erratic provisioning pattern suggests that management's credit loss estimates are highly sensitive to short-term changes in the loan book or local economic conditions. Analysts should interpret these swings with caution, as they may mask the true cost of credit risk in the bank's commercial real estate and residential loan portfolios.
Analysis of the cash flow statement reveals that the OCF/NI ratio has reached extreme levels, such as 2818.84 in 2026Q2, which indicates that the reported cash flow from operations is heavily distorted by non-operating balance sheet movements rather than core banking profitability.
The disconnect between net income and operating cash flow suggests that the cash flow statement is a poor proxy for the bank's actual operational health. Investors should focus on the balance sheet and income statement to understand the bank's true performance, as the cash flow statement appears to be dominated by large-scale asset liquidations and debt adjustments.
Quick answers to the most common questions about buying MBBC stock.
Marathon Bancorp, Inc. (MBBC) generated $1.4M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Marathon Bancorp, Inc. (MBBC) generated $1.3M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Marathon Bancorp, Inc. (MBBC) spent $0.2M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, Marathon Bancorp, Inc. (MBBC) spent $0.1M on share repurchases. This shows the company's commitment to returning capital to its equity investors.